{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:04:45Z","timestamp":1761930285938,"version":"3.41.2"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001771","name":"University of Newcastle Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p><jats:italic>Sarcoptic scabiei<\/jats:italic> is an invasive parasitic mite that negatively impacts wombats, causing sarcoptic mange disease, characterized by alopecia, intense pruritus, hyperkeratosis, and eventual mortality. Evidence suggests that wombats may be unable to recovery from infection without the assistance of treatments. Transdermal drug delivery is considered the most ideal route of administration for <jats:italic>in situ<\/jats:italic> treatment in free-ranging wombats, as it is non-invasive and avoids the need to capture affected individuals. Although there are effective antiparasitic drugs available, an essential challenge is adequate administration of drugs and sufficient drug retention and absorption when delivered. This review will describe the implications of sarcoptic mange on the physiology of wombats as well as discuss the most widely used antiparasitic drugs to treat <jats:italic>S. scabiei<\/jats:italic> (ivermectin, moxidectin, and fluralaner). The prospects for improved absorption of these drugs will be addressed in the context of pathophysiological and pharmaceutical considerations influencing transdermal drug delivery in wombats with sarcoptic mange.<\/jats:p>","DOI":"10.3389\/fvets.2022.944578","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T08:07:46Z","timestamp":1656403666000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Pathophysiological and Pharmaceutical Considerations for Enhancing the Control of Sarcoptes scabiei in Wombats Through Improved Transdermal Drug Delivery"],"prefix":"10.3389","volume":"9","author":[{"given":"Jaskaran","family":"Bains","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Carver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.20506\/rst.21.2.1335","article-title":"Sarcoptic manage in wildlife","volume":"21","author":"Pence","year":"2002","journal-title":"Rev Sci Tech."},{"key":"B2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pt.2015.01.007","article-title":"Emerging infectious diseases of wildlife: a critical perspective","volume":"31","author":"Tompkins","year":"2015","journal-title":"Trends Parasitol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13071-016-1578-2","article-title":"The emergence of sarcoptic mange in Australian wildlife: an unresolved debate","volume":"9","author":"Fraser","year":"2016","journal-title":"Parasit Vectors."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0004389","DOI":"10.1371\/journal.pntd.0004389","article-title":"Prospects for moxidectin as a new oral treatment for human scabies","volume":"10","author":"Mounsey","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"B5","unstructured":"2022"},{"key":"B6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/biosci\/biab106","article-title":"Sustaining transmission in different host species: the emblematic case of Sarcoptes scabiei","volume":"72","author":"Browne","year":"2022","journal-title":"Bioscience"},{"key":"B7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.7589\/2018-04-101","article-title":"Expanded molecular typing of Sarcoptes scabiei provides further evidence of disease spillover events in the epidemiology of sarcoptic mange in Australian marsupials","volume":"55","author":"Fraser","year":"2019","journal-title":"J Wildl Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13071-017-2234-1","article-title":"A review of Sarcoptes scabiei: past, present and future","volume":"10","author":"Arlian","year":"2017","journal-title":"Parasit Vectors."},{"key":"B9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2133.1981.tb00977.x","article-title":"Host-parasite relationships in hyperkeratotic (Norwegian) scabies: pathological and immunological findings","volume":"105","author":"Van Neste","year":"1981","journal-title":"Br J Dermatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/jmedent\/43.3.539","article-title":"Presence of host immunoglobulin in the gut of Sarcoptes scabiei (Acari: Sarcoptidae)","volume":"43","author":"Rapp","year":"2006","journal-title":"J Med Entomol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/tbed.12770","article-title":"Sarcoptic mange in wombats - a review and future research directions","volume":"65","author":"Old","year":"2018","journal-title":"Transbound Emerg Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1590\/S1984-82502013000300004","article-title":"Basic considerations in the dermatokinetics of topical formulations","volume":"49","author":"Nair","year":"2013","journal-title":"Braz J Pharm Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1111\/1365-2664.13467","article-title":"Population-scale treatment informs solutions for control of environmentally transmitted wildlife disease","volume":"56","author":"Martin","year":"2019","journal-title":"J Appl Ecol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13071-020-04500-9","article-title":"Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use","volume":"14","author":"Wilkinson","year":"2021","journal-title":"Parasit Vectors."},{"key":"B15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.addr.2003.10.021","article-title":"Transdermal drug delivery: past progress, current status, and future prospects","volume":"56","author":"Langer","year":"2004","journal-title":"Adv Drug Deliv Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1071\/WR07067","article-title":"Home range, burrow-use and activity patterns in common wombats (Vombatus ursinus)","volume":"35","author":"Evans","year":"2008","journal-title":"Wildl Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijppaw.2021.08.003","article-title":"Environmental suitability of bare-nosed wombat burrows for Sarcoptes scabiei","volume":"16","author":"Browne","year":"2021","journal-title":"Int J Parasitol Parasites Wildl"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0149749","DOI":"10.1371\/journal.pone.0149749","article-title":"Sarcoptes scabiei: the mange mite with mighty effects on the common wombat (Vombatus ursinus)","volume":"11","author":"Simpson","year":"2016","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1751-0813.1998.tb12389.x","article-title":"Sarcoptic mange in wombats","volume":"76","author":"Skerratt","year":"1998","journal-title":"Aust Vet J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7589\/0090-3558-39.1.179","article-title":"Clinical response of captive common wombats (Vombatus ursinus) infected with Sarcoptes scabiei var. wombati","volume":"39","author":"Skerratt","year":"2003","journal-title":"J Wildl Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"180018","DOI":"10.1098\/rsos.180018","article-title":"The cascading pathogenic consequences of Sarcoptes scabiei infection that manifest in host disease","volume":"5","author":"Martin","year":"2018","journal-title":"R Soc Open Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.7589\/0090-3558-39.1.193","article-title":"Cellular response in the dermis of common wombats (Vombatus ursinus) infected with Sarcoptes scabiei var. wombati","volume":"39","author":"Skerratt","year":"2003","journal-title":"J Wildl Dis."},{"volume-title":"Dermatosis in a Common Wombat (Vombatus ursinus) (Case 760.1).","year":"2021","author":"Rose","key":"B23"},{"key":"B24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.7589\/0090-3558-35.4.633","article-title":"Distribution of life cycle stages of Sarcoptes scabiei var. wombati and effects of severe mange on common wombats in Victoria","volume":"35","author":"Skerratt","year":"1999","journal-title":"J Wildl Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1071\/ZO02062","article-title":"The effects of sarcoptic mange on the behaviour of wild common wombats (Vombatus ursinus)","volume":"53","author":"Skerratt","year":"2004","journal-title":"Aust J Zool."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00436-020-07012-8","article-title":"The use of Cydectin(R) by wildlife carers to treat sarcoptic mange in free-ranging bare-nosed wombats (Vombatus ursinus)","volume":"120","author":"Old","year":"2021","journal-title":"Parasitol Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.addr.2018.04.008","article-title":"Drug delivery systems and materials for wound healing applications","volume":"127","author":"Saghazadeh","year":"2018","journal-title":"Adv Drug Deliv Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2133.2011.10572.x","article-title":"Human hair follicle: reservoir function and selective targeting","volume":"165","author":"Blume-Peytavi","year":"2011","journal-title":"Br J Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/S0169-409X(02)00113-8","article-title":"Drug delivery routes in skin: a novel approach","volume":"54","author":"Barry","year":"2002","journal-title":"Adv Drug Deliv Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/jmor.10118","article-title":"Distribution of keratin and associated proteins in the epidermis of monotreme, marsupial, and placental mammals","volume":"258","author":"Alibardi","year":"2003","journal-title":"J Morphol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00436-022-07460-4","article-title":"Drug dose and animal welfare: important considerations in the treatment of wildlife","volume":"121","author":"Mounsey","year":"2022","journal-title":"Parasitol Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3390\/pharmaceutics13060909","article-title":"Ion pairs for transdermal and dermal drug delivery: a review","volume":"13","author":"Cristofoli","year":"2021","journal-title":"Pharmaceutics."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/17425247.2017.1306054","article-title":"Seeking better topical delivery technologies of moisturizing agents for enhanced skin moisturization","volume":"15","author":"Kim","year":"2018","journal-title":"Expert Opin Drug Deliv."},{"key":"B35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1071\/AM20001","article-title":"Incidence of sarcoptic mange in bare-nosed wombats (Vombatus ursinus)","volume":"43","author":"Stannard","year":"2020","journal-title":"Aust Mammal."},{"key":"B36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s13346-020-00864-8","article-title":"Predicting topical drug clearance from the skin","volume":"11","author":"Maciel Tabosa","year":"2021","journal-title":"Drug Deliv Transl Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ijpddr.2012.04.001","article-title":"Moxidectin and the avermectins: consanguinity but not identity","volume":"2","author":"Prichard","year":"2012","journal-title":"Int J Parasitol Drugs Drug Resist."},{"key":"B38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cbi.2005.11.002","article-title":"Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3)","volume":"159","author":"Lespine","year":"2006","journal-title":"Chem Biol Interact."},{"key":"B39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0166-6851(97)00215-6","article-title":"Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog","volume":"91","author":"Xu","year":"1998","journal-title":"Mol Biochem Parasitol."},{"volume-title":"Guidelines for the Treatment of Australian Wildlife With Sarcoptic mange, Part 2 - Literature Review. NESP Threatened Species Recovery Project 1.4.4 report","year":"2021","author":"Skerratt","key":"B40"},{"key":"B41","doi-asserted-by":"publisher","first-page":"107961","DOI":"10.1016\/j.exppara.2020.107961","article-title":"The scabicide effect of moxidectin in vitro and in experimental animals: parasitological, histopathological and immunological evaluation","volume":"217","author":"Sharaf","year":"2020","journal-title":"Exp Parasitol."},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1079\/9780851996172.0000","volume-title":"Macrocyclic Lactones in Antiparasitic Therapy","author":"Vercruysse","year":"2002"},{"key":"B43","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ecoenv.2017.06.016","article-title":"Aquatic toxicity of ivermectin in cattle dung assessed using microcosms","volume":"144","author":"Mesa","year":"2017","journal-title":"Ecotoxicol Environ Saf."},{"key":"B44","doi-asserted-by":"publisher","first-page":"312","DOI":"10.7589\/2012-10-256","article-title":"Effects and treatment of sarcoptic mange in southern hairy-nosed wombats (Lasiorhinus latifrons)","volume":"49","author":"Ruykys","year":"2013","journal-title":"J Wildl Dis."},{"volume-title":"Ivermectin. Saunders Handbook of Veterinary Drugs","year":"2016","author":"Papich","key":"B45"},{"key":"B46","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/ph13080196","article-title":"Avermectin derivatives, pharmacokinetics, therapeutic and toxic dosages, mechanism of action, and their biological effects","volume":"13","author":"El-Saber Batiha","year":"2020","journal-title":"Pharmaceuticals."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e12891","DOI":"10.1111\/and.12891","article-title":"Effects of ivermectin and its combination with alpha lipoic acid on expression of IGFBP-3 and HSPA1 genes and male rat fertility","volume":"50","author":"El-Maddawy","year":"2018","journal-title":"Andrologia."},{"key":"B48","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1756-3305-2-S2-S5","article-title":"Moxidectin: a review of chemistry, pharmacokinetics and use in horses","volume":"2","author":"Cobb","year":"2009","journal-title":"Parasit Vectors."},{"key":"B49","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1124\/dmd.109.030700","article-title":"Role of P-glycoprotein in the disposition of macrocyclic lactones: a comparison between ivermectin, eprinomectin, and moxidectin in mice","volume":"38","author":"Kiki-Mvouaka","year":"2010","journal-title":"Drug Metab Dispos."},{"key":"B50","doi-asserted-by":"publisher","first-page":"643","DOI":"10.7589\/0090-3558-47.3.643","article-title":"Pharmacokinetics of moxidectin in the southern hairy-nosed wombat (Lasiorhinus latifrons)","volume":"47","author":"Death","year":"2011","journal-title":"J Wildl Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13071-019-3340-z","article-title":"The treatment of sarcoptic mange in wildlife: a systematic review","volume":"12","author":"Rowe","year":"2019","journal-title":"Parasit Vectors."},{"key":"B52","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fvets.2019.00440","article-title":"Use of slow-release injectable moxidectin for treatment of Dirofilaria immitis infection during pregnancy","volume":"6","author":"Alberigi","year":"2019","journal-title":"Front Vet Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2460\/ajvr.2000.61.482","article-title":"Safety of moxidectin in avermectin-sensitive collies","volume":"61","author":"Paul","year":"2000","journal-title":"Am J Vet Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-4017(00)00357-5","article-title":"Field efficacy of moxidectin in dogs and rabbits naturally infested with Sarcoptes spp","volume":"93","author":"Wagner","year":"2000","journal-title":"Vet Parasitol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00436-021-07092-0","article-title":"A systematic review of moxidectin as a treatment for parasitic infections in mammalian species","volume":"120","author":"Schraven","year":"2021","journal-title":"Parasitol Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/ijerph14020154","article-title":"Mosquitocidal activity and mode of action of the isoxazoline fluralaner","volume":"14","author":"Jiang","year":"2017","journal-title":"Int J Environ Res Public Health."},{"key":"B57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1756-3305-7-85","article-title":"Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration","volume":"7","author":"Kilp","year":"2014","journal-title":"Parasit Vectors."},{"key":"B58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-3305-7-87","article-title":"Safety of fluralaner chewable tablets (Bravecto), a novel systemic antiparasitic drug, in dogs after oral administration","volume":"7","author":"Walther","year":"2014","journal-title":"Parasit Vectors."},{"key":"B59","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s13071-018-3170-4","article-title":"Safety of topical administration of fluralaner plus moxidectin concurrently with praziquantel in cats","volume":"11","author":"Walther","year":"2018","journal-title":"Parasit Vectors."},{"key":"B60","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1756-3305-7-86","article-title":"Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-\/-) collies after oral administration","volume":"7","author":"Walther","year":"2014","journal-title":"Parasit Vectors."},{"key":"B61","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3109\/10717544.2014.935532","article-title":"Permeation enhancer strategies in transdermal drug delivery","volume":"23","author":"Marwah","year":"2016","journal-title":"Drug Deliv."},{"key":"B62","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1023\/A:1016060403438","article-title":"Current status and future prospects of transdermal drug delivery","volume":"13","author":"Guy","year":"1996","journal-title":"Pharm Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s11095-010-0292-6","article-title":"The rule of five for non-oral routes of drug delivery: ophthalmic, inhalation and transdermal","volume":"28","author":"Choy","year":"2011","journal-title":"Pharm Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2174\/1567201812666150804104600","article-title":"Chemical penetration enhancers for transdermal drug delivery - success and challenges","volume":"12","author":"Ita","year":"2015","journal-title":"Curr Drug Deliv."},{"key":"B65","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3389\/fphar.2015.00219","article-title":"Lipid-based nano-delivery systems for skin delivery of drugs and bioactives","volume":"6","author":"Hua","year":"2015","journal-title":"Front Pharmacol."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.944578\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T08:08:06Z","timestamp":1656403686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.944578\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":65,"alternative-id":["10.3389\/fvets.2022.944578"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2022.944578","relation":{},"ISSN":["2297-1769"],"issn-type":[{"type":"electronic","value":"2297-1769"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"article-number":"944578"}}